subcutaneous Enoxaparin
3 treatments and conditions followed through the public trial records. Not medical advice. How a status is set
Treatments and conditions
| Treatment and condition | Where it stands | Trials |
|---|---|---|
| subcutaneous Enoxaparin for fetal growth retardation | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| subcutaneous Enoxaparin for pre-eclampsia | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |
| subcutaneous Enoxaparin for premature birth | Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person) | 1 |